; excessive transfusion requirements (n=3); fever, ileus and mild chest syndrome or pneumonia(n=1); parents wanted a cure for their child's sickle cell disease(n=1); Unrelated cord blood: excessive transfusion requirements (n=6); cerebral vasculopathy(n=1); combination of acute chest and pain crisis (chronically ill) (n=1); extensive complications from sickle cell(n=1); rare disease type(n=1); best long-term, lifelong option for patient (n=1); HLA identical sibling: recurrent priapism (n=1); abnormal tcd-mri/mra with narrowing of supraclinoid portions of the internal carotid arteries bilat(n=1); excessive transfusion requirements (n=5); acute chest syndrome; pain; transfusions(n=1); cardiomyopathy/pulmonary stenosis(n=1); cranial vasculopathy therefore stroke prevention(n=1); develop allo antibodies, increasing hgb, decreased response to hydroxyurea (n=1); elevated transcranial Doppler(n=1); family wanted to move back to nigeria where there is not modern care nor safe transfusion(n=1); increased frequency of pain crisis, at significant risk end organ damage and dysfunction in adulthood(n=1); matched sib and hx pain crisis(n=1); pain; avn; mri changes; to correct sickle cell disease(n=1); presence of silent infarcts on mri(n=1); sickle cell disease(n=1);
Well-matched unrelated: excessive transfusion requirements (n=1); both acute chest and pain crisis(n=1); improved quality of life(n=1); Other unrelated: excessive transfusion requirements (n=2); cure sickle cell (n=1); liver transplant (n=1); osteonecrosis/requiring hip replacement neuropathy-vision loss (n=1) ** Related cord blood: HbSC (n=1); Unrelated cord blood: HbS beta+ thalassemia (n=1); HbSC (n=1); HbSHakkari (BETA 31 LEU -> ARG) (n=1); HLA identical sibling: HbSbarts (n=1); HbSC (n=1) Well-matched unrelated: HbSC (n=1); HbSDPunjabi (n=1); HbSOArab (n=1) 
Figure legend
A. Provides a flow diagram of the various data sources used for study analysis. Outcomes data for analysis was provided by information in CRFs from CIBMTR; while healthcare utilization analysis included combined data from PHIS and TED forms from CIBMTR. This dual analysis was largely due to the minimal overlap between PHIS and CRF data.
B.
Within the TED/PHIS healthcare utilization data, specific data sources were used in each transplant period. All data for descriptive analysis of healthcare utilization was provided by PHIS. PHIS was also used to make disease severity determinations; while, TED was used to compare transplant related variables (i.e., donor type, conditioning, etc.).
C.
Depicts the statistically significant difference in overall survival between all transplant recipients and recipients by donor type with HLA identical sibling and cord blood showing the highest survival. 
